Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,821 JPY | +2.92% | -1.67% | 0.00% |
May. 06 | Calliditas Therapeutics' Potential Head and Neck Cancer Treatment Meets Secondary Endpoints | MT |
May. 06 | UK Tribunal Greenlights GBP790 Million Lawsuit vs Prysmian, Nexans, NKT | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
0.00% | 2.12B | |
+14.60% | 330B | |
-8.24% | 65.97B | |
+0.14% | 30.2B | |
+23.43% | 23.68B | |
+11.39% | 14.4B | |
+14.54% | 9.84B | |
+23.15% | 9.55B | |
-6.89% | 6.56B | |
+3.68% | 4.71B |
- Stock Market
- Equities
- 141A Stock
- News Trial Holdings Inc.
- Hengrui Pharma Gets Nod to Trial Insulin Aspart Injection; Shares Up 3%